idursulfase-IT
HGT-HIT-094
Phase 3 mab active
Quick answer
idursulfase-IT for Hunter Syndrome is a Phase 3 program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 4 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Hunter Syndrome
- Phase
- Phase 3
- Modality
- mab
- Status
- active